EXREGMED (EXcellence in REGenerative MEDicine)

There is a newer version of the record available.

Published November 10, 2025 | Version v1
Preprint Open

Galectin-3 as a therapeutic target in pulmonary hypertension: Molecular mechanisms, drug development directions, and emerging clinical applications

Authors/Creators

  • 1. ROR icon Czech Academy of Sciences, Institute of Physiology
  • 2. Institute of Microbiology of the Czech Academy of Sciences
  • 3. Institute of Physiology of the Czech Academy of Sciences
  • 4. ROR icon Czech Academy of Sciences, Institute of Microbiology

Files

Preprint_Sedlar_et_al_2025.pdf

Files (1.6 MB)

Name Size
md5:4cfcaefee11a261136ebab9047ceba69
1.6 MB Preview Download

Additional details

Funding

Ministry of Education Youth and Sports
National Institute for Research of Metabolic and Cardiovascular Diseases LX22NPO5104
Ministry of Education Youth and Sports
Excellent Research in Regenerative Medicine CZ.02.01.01/00/22_008/0004562
Czech Science Foundation
Galectin-3 as a target molecule for the reversal of vascular remodelling in hypoxic pulmonary hypertension GA22-00317S